Latest filing published 19 Feb 2021 for GlaxoSmithKline plc.
Insider track record
No signal scores available.
I Whyte: trading record in brief
I Whyte is a declared insider of GlaxoSmithKline plc, with filings sourced from RNS (LSE). In total, 6 filings cover trades dated from 20 February 2020 to 18 February 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 19 February 2021, the filings show a transaction in GlaxoSmithKline plc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to I Whyte
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,870 sharesN/AISIN GB0009252882FCA-NSM:3886010-2
- 1,052 shares@ £13.8802London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847478-4
- 1,015 shares@ £14.19London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746889-4
- 883 shares@ £16.1054100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3653560-4
- 1,108 shares@ £15.3297London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3561637-4
- 10,838 sharesN/AISIN GB0009252882FCA-NSM:LSE20200221130015_3502125_20200331164942702_21042-2
6 of 6 declarations